Diapositiva 1

1
RED DE TRASTORNOS ADICTIVOS Spain Network on Drug
Addiction A successful model of colaborative
research in drug addiction Fernando Rodriguez de
Fonseca Fundación IMABIS de Málaga
2
RED DE TRASTORNOS ADICTIVOS Spain Network on Drug
Addiction
3

• HISTORICAL BACKGROUND
•  
• The Goverment of SPAIN launches a Call for
  Excelence Research Networks
• Following FP6 model
•  
• 2004 A proposal named Red de Trastornos Adictivos
  is awarded 1.8 m for 3 years
• End of the program. A one year continuation
  grant 700.000 awarded after
• International Evaluation
• New Call launched for 4 years proposals
• A new grant is awarded after the evaluation. 4
  year, 4.5 mE up to 2010
• New composition of the Network
• -2010 New strategic plan being developed. New
  aims and programs.
• Internal and external evaluation. Renovation
  proces starts Oct 1st 2009
•  

4
Description of the Network 1º Program 2003-2006
22 groups
3 epidemiology 3 clinical 16 basic
5
FINANTIAL SUPPORT
6
Description of the Network 2º Program 2007-2010
21 groups
F. CC. Univ. Autónoma Barcelona Antonio Armario
García
F. CC. Salud Univ. Pompeu Fabra Rafael Maldonado
Hospital Germans Trias I Pujol Roberto Muga
F. Psicología Univ. Complutense Miguel Navarro
García
Hospital de la Santa Creu y Sant Pau Jose Perez
de Los Cobos
F. Medicina. Univ. Complutense Isabel Colado Megia
F. Psicologia . UNED Emilio Ambrosio Flores
F. Medicina Universitat Miguel Hernandez Carmen
de Felipe Fernández
Instituto de Quimica Medica CSIC Pilar Goya
F. CC. Humanas y Sociales. U. Jaume I Carlos
González Aragón
Instituto de Investigaciones Citológicas
Consuelo Guerri Sirera
F. Psicología. Universitat de Valencia José
Miñarro López
Hospital La Fe Universidad de Valencia Jaume
Renau Piqueras
Universidad Cardenal Herrera Juan José Canales
7
FINANTIAL SUPPORT WAS DIFFERENT IN THE SECOND
PROGRAM

• SUPPORT BASED STRICTLY ON SCIENTIFIC EXCELLENCE
• CLINICAL GROUPS WERE INITIALLY NOT SUPPORTED
• A BIOBANK INFRAESTRUCTURE WAS FUNDED
• ECONOMIC SUPPORT WAS THREE TIMES THAT OF
• FIRST PROGRAM
• THERE WAS A POSSIBIITY OF INCORPORATION OF NEW
  GROUPS
• CLAIM FOR REINCOPORATION OF CLINICIANS

8

• In 2007 the network incorporated 10 new groups

9
RATIONALE AND RESEARCH AIMS

• ADDICTION IS A DISEASE THAT REQUESTS
• INTENSE RESEARCH EFFORTS
• CREATE A COMMON RESEARCH SPACE
• SUPPORT COOPERATIVE RESEARCH
• INTEGRATE BASIC, CLINICAL AND EPIDEMIOLOGICAL
  RESEARCH
• FACILITATE MOBILITY AND EXCHANGE OF SCIENTISTS
• CREATE A WEB-BASED PLATFORM FOR SCIENTIFIC
  EDUCATION
• COMMUNICATION OF FINDINGS TO THE SCIENTIFIC
  COMMUNITY
• AND TO THE SOCIETY

10
MANAGEMENT STRUCTURE
11

• MANAGEMENT AND RESEARCH AREAS
• Coordination Fernando Rodríguez de Fonseca
  (Fundación IMABIS)
• Vulnerability to drug abuse. Emilio Fernandez
  Espejo (Universidad de Sevilla) y Emilio Ambrosio
  (UNED)
• Determinants and effects of policonsumption
  Maribel Colado (Universidad Complutense de
  Madrid). Marta Torrens Melich (IMIM-Hospital del
  Mar).
• Drug abuse-associated disorders Roberto Muga
  (Hospital German Trias i Pujol) y Magí Farré
  (Farmacología IMIM)
• New treatments for drug abuse Miguel Casas
  (Hospital Vall DHebron) y Rafael Maldonado
  (Universidad Pompeu Fabra)
• Education and Scientific Communication José
  Miñarro (Universidad de Valencia) y Francisco
  Javier Alvarez (Univeridad de Valladolid)
• Biobank Dirigido por Carmen de Felipe
  (Universidad Miguel Hernandez de Alicante)

12

• External Sicentific Committee proposed for 2010
  evaluation
• 1. Dr. Ian Kitchen
• School of Biomedical and Molecular Sciences.
  University of SurreyGuildford. Surrey
• 2. Prof. Michael Farrell Chairman Scientific
  Committee
• EMCDDA
• London
• 3. Prof. Dr. Rainer SpanagelDepartment of
  Psychopharmacology. Zentral Institute of Mental
  HealthJ5 68159 Mannheim
• 4. Walter Fratta
• Institute of Neuroscience
• Department of Neuroscience and Centre of
  Excellence "Neurobiology of Dependence,"
  Cittadella Universitaria di Monserrato,
• University of Cagliari

13
RESULTS OF SCIENTIFIC ACTIVITY 2005-2010

• 31 GROUPS RECEIVED FINANTIAL SUPPORT STRICTLY
• FOR CONTRACTING AND MOBILITY
• 5 CLINICAL GROUPS AND A PROFESSIOINAL ASSOCIATION
• FOR THE TREATMENT OF PATIENTS
• 87 DOCTORS, 93 PhD STUDENTS AND 14 TECHNICIANS
• 7.8 MILLION EUROS BUDGET
• RESEARCH GROUPS WERE AWARDED
• 15.456.460 IN RESEARCH GRANTS (OWN FINANTIAL
  SUPPORT)

14
DATOS DE ACTIVIDAD 2005-2009

• UP TO DATE 385 SCIENTIFIC DOCUMENTS IN
• PEER-REVIEWED JOURNALS
• MORE THAN 15.000 CITATIONS OF THOSE PAPERS
• COOPERATIVE PUBLICATIONS ROSE FROM 12 TO 27
• 143 RESEARCH GRANTS FROPM PUBLIC AND PRIVATE
  SOURCES
• 19 INDUSTRIAL PATENTS

15
Publications 2003-2005
ANALYSIS OF SCIENTIFIC IMPACT
16
WE PERFORMED 9 SCIENTIFIC AND 8
MANAGEMENT MEETINGS RTA HAS BEEN PRESENT IN
MOST SCIENTIFIC MEETINGS AND CONGRESS HELD IN
SPAIN
17
WEB PROJECTS
RED DE TRASTORNOS ADICTIVOS

• Miguel Romero Cuevas
• Maria Esther Martin García
• redrta_at_wanadoo.es

18
CORPORATE IMAGE
19
WEB-BASED PLATFORM FOR CONTINUOUS EDUCATION

• OWN DEVELOPED MOODLE PLATFORM
• TECHNICAL COURSES ON LINE (FREE
  SOFTWARE) REFERENCE MANAGER
• WRITING PAPERS AND GRANTS
• DESIGN OF SCIENTIFIC IMAGES
• THEORETICA L COURSES
• PSYCHOSTIMULANTS (ANNUAL)
• CLINICAL CASES ON DRUG ADDICTION (ANNUAL)
• NEUROBIOLOGY OF ALCOHOLISM
• MORE THAN 500 STUDENTS
• (35-50 PER COURSE)

20
RTA PLATFORM
http//formacion.redrta.net
21
RTA PLATFORM
http//formacion.redrta.net

• Journal Club

22
Blog RTA
http//www.trastornosadictivos.es
23
Scientific Surveillance
http//www.redrta.es
24
 BioBank Red de Trastornos Adictivos
Contact Carmen de Felipe, Macarena Herrera,
Luis Navarro Tlf 96 591 9553 / 96 591
9336 e-mail biobancorta_at_umh.es
25
STRATEGIC AIMS BioBanK RTA

• Obtain, prepare and storage biological samples
  and clinical data of well phenotyped populations
  of patients diagnosticated of drug abuse
• Distribute samples of DNA to research groups
  of the scientific community
• Ensure a rational use of samples, by a careful
  examination of scientific, legal and ethic
  aspects of projects

26
BioBank RTA FUNCTIONAL STRUCTURE
Scientific CMT
DIRECTION Dr. Fernando Rodriguez de
Fonseca Dr- Carmen de Felipe
F. Rodriguez de Fonseca C. De Felipe B.
Perez-Galvez J. Perez de los Cobos J. Alvarez I.
Rivas
SECRETARY AND ADMINISTRATION Isabel Romero

SUPPORT UNIT Esther Martín
QUALITY UNIT Victor Severá (COFA)
TECHNICAL COORDINATION Dra. Carmen de Felipe
SCIENTIFIC PROJECTS
PRODUCTION AND STORAGE Luis Navarro y Eva del Rio
MANAGEMENT OF PRODUCTS
CELL IMMORTALIZATION Macarena Herrera
27

• WEAKNESSES OF THE PROJECT
• UNIQUENESS THERE IS NO ALTERNATIVE FUNDING
  PROGRAM TO THIS PROJECT (AT EUROPEAN, NATIONAL OR
  PRIVATE LEVELS)
• RESEARCHERS STILL RELUCTANT TO COOPERATIVE
  PROJECTS (FINANTIAL SUPPORT POR COOPERATIVE
  GRANTS IS RISKY)
• PERCEPTION OF EITHER MORE CONTROL OR LOSS OF
  AUTONOMY IN SCIENTIFIC DEVELOPMENT
• LOW SUPPORT TO CLINICIANS AND EPIDEMIOLOGY GROUPS
• CONTINUITY UNSTABLE RENOVATION REQUIREMENTS AND
  STRICT GOVERNMENT BUDGET DEPENDENCY (ECONOMICAL
  CRISIS?)

28
ACKNOWLEDGEMENTS

• MINISTERIO DE SANIDAD
• INSTITUTO DE SALUD CARLOS III
• PLAN NACIONAL SOBRE DROGAS
• MINISTERIO DE CIENCIA E INNVACION
• EUROPEAN COMMISSION - EMCDDA
• FUNDACION IMABIS MALAGA

29
ACKNOWLEDGEMENTS

• RESEARCHERS FROM THE RTA
• ESTHER MARTIN
• MIGUEL ROMERO
• ALEJANDRO GORNEMANN